What is Wegovy
Wegovy is a prescription medication specifically designed for weight management. It contains semaglutide, an active ingredient that mimics a hormone called GLP-1 (glucagon-like peptide-1), which targets areas of the brain involved in regulating appetite and food intake. By enhancing feelings of fullness and reducing hunger, Wegovy helps individuals reduce their calorie intake and achieve significant weight loss.
Numerous clinical trials have demonstrated the efficacy and safety of Wegovy. In these studies, participants taking Wegovy lost an average of 15% of their body weight over 68 weeks, with some achieving up to 20% weight reduction. These results were significantly higher compared to those who received a placebo. Wegovy is administered via a once-weekly subcutaneous injection and is intended for adults with obesity or those who are overweight with at least one weight-related condition.